MTNB Matinas BioPharma Holdings,...

NYSE matinasbiopharma.com


$ 1.24 $ 0.03 (2.56 %)    

Tuesday, 11-Nov-2025 15:49:55 EST
QQQ $ 625.72 $ 0.00 (0 %)
DIA $ 480.25 $ 0.00 (0 %)
SPY $ 685.57 $ 0.00 (0 %)
TLT $ 89.77 $ 0.00 (0 %)
GLD $ 379.67 $ 0.00 (0 %)
$ 1.2
$ 1.28
$ 0.99 x 2
$ 1.86 x 210
-- - --
$ 0.47 - $ 3.09
4,936
na
7.69M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 04-15-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-27-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-08-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-29-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-09-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-13-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-16-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 matinas-biopharma-hldgs-q3-eps-040-up-from-085-yoy

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.40) per share. This is a 52.94 percent increase over losse...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 matinas-biopharma-doubles-authorized-common-shares-to-500m-following-shareholder-approval

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year. On August 6, 2025, Matinas BioPharma Holdi...

 111-equity-group-increases-stake-to-517-in-matinas-biopharma-as-strategic-review-underway-including-asset-sale-of-mat2203-103m-cash-reported-which-would-equate-to-roughly-213-cash-per-share-value

111 Equity Group, LLC ("111 Equity") and its principal filed a Schedule 13D with the Securities and Exchange Commission...

 matinas-biopharma-receives-nyse-noncompliance-notice

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicati...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION